VEP Latency Delay Reflects Demyelination Beyond the Optic Nerve in the Cuprizone Model

Invest Ophthalmol Vis Sci. 2024 Nov 4;65(13):50. doi: 10.1167/iovs.65.13.50.

Abstract

Purpose: Remyelination therapies are advancing for multiple sclerosis, focusing on visual pathways and using visual evoked potentials (VEPs) for de/remyelination processes. While the cuprizone (CZ) model and VEPs are core tools in preclinical trials, many overlook the posterior visual pathway. This study aimed to assess functional and structural changes across the murine visual pathway during de/remyelination.

Methods: One group of C57BL/6 mice underwent a CZ diet for 6 weeks to simulate demyelination, with a subset returning to a regular diet to induce remyelination. An additional group was fed a protracted CZ diet for 12 weeks to maintain chronic demyelination. Visual function was evaluated using electrophysiological recordings, including scotopic threshold responses (STRs) and electroretinograms (ERGs), with VEPs serving as a key biomarker for overall pathway health. Tissues from eyes, brains, and optic nerves (ONs) were collected at different time points for structural analysis.

Results: Our results demonstrated significant effects on VEPs, including increased N1 latencies and reduced amplitudes in the CZ mouse model. However, retinal function remained unaffected, as evidenced by unchanged STRs, ERGs, and retinal ganglion cell counts. Analysis of ONs revealed morphological changes, characterized by a significantly decreased axon diameter in the core region compared to the subpial region. Additionally, there was a significant increase in the g-ratio of the core region at 12 weeks CZ compared to controls. Immunofluorescence further demonstrated a decrease in myelin basic protein levels at 6 and 12 weeks in CZ animals. Interestingly, the dorsal lateral geniculate nucleus and primary visual cortex (V1) exhibited similar myelin changes, correlating with VEP latency alterations.

Conclusions: These data reveal that interpreting VEP latency solely as a marker for ON demyelination is incomplete. Previous preclinical studies have overlooked the posterior visual pathways, necessitating a broader interpretation of VEP latency to cover the entire visual pathway.

MeSH terms

  • Animals
  • Chelating Agents / toxicity
  • Cuprizone* / toxicity
  • Demyelinating Diseases* / chemically induced
  • Demyelinating Diseases* / pathology
  • Demyelinating Diseases* / physiopathology
  • Disease Models, Animal*
  • Electroretinography*
  • Evoked Potentials, Visual* / physiology
  • Female
  • Male
  • Mice
  • Mice, Inbred C57BL*
  • Myelin Sheath / pathology
  • Optic Nerve* / pathology
  • Optic Nerve* / physiopathology
  • Remyelination / physiology
  • Retina / pathology
  • Retina / physiopathology
  • Retinal Ganglion Cells / pathology
  • Visual Pathways / pathology
  • Visual Pathways / physiopathology

Substances

  • Cuprizone
  • Chelating Agents